University Of Maryland School Of Medicine Begins Novavax COVID-19 Vaccine Study For Ages 12-17
The University of Maryland School of Medicine began the expansion of clinical trials for Novavax COVID-19 vaccine in teenagers aged 12 through 17 this week.